- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/38 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Patent holdings for IPC class C07K 16/38
Total number of patents in this class: 259
10-year publication summary
|
28
|
23
|
23
|
19
|
27
|
27
|
19
|
11
|
11
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1118 |
36 |
| Novo Nordisk A/S | 2302 |
15 |
| Pfizer Inc. | 3375 |
13 |
| Bayer HealthCare LLC | 1302 |
6 |
| ImCare Biotech, LLC, DBA Imcare Biotech | 8 |
6 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
6 |
| Bayer AG | 3470 |
5 |
| Daiichi Sankyo Company, Limited | 1890 |
5 |
| Translational Sciences Inc. | 11 |
5 |
| Ampsource Biopharma Shanghai Inc. | 45 |
5 |
| Green Cross Corporation | 215 |
4 |
| IDEXX Laboratories, Inc. | 885 |
4 |
| Rutgers, The State University of New Jersey | 1959 |
4 |
| Suzhou Alphamab Co., Ltd. | 46 |
4 |
| Janssen Pharmaceutica N.V. | 3213 |
3 |
| Takeda Pharmaceutical Company Limited | 2718 |
3 |
| Alexion Pharmaceuticals, Inc. | 640 |
3 |
| Amicus Therapeutics, Inc. | 352 |
3 |
| Hong Guan Ltd. | 11 |
3 |
| Katholieke Universiteit Leuven | 1261 |
3 |
| Other owners | 123 |